Letizia Riva

2.5k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Letizia Riva is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Letizia Riva has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Internal Medicine. Recurrent topics in Letizia Riva's work include Atrial Fibrillation Management and Outcomes (11 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Letizia Riva is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Letizia Riva collaborates with scholars based in Italy, Lebanon and Slovakia. Letizia Riva's co-authors include Paolo Ciliberti, Claudio Rapezzi, Fabrizio Salvi, Angelo Branzi, Ornella Leone, Enrica Perugini, Maria Letizia Bacchi Reggiani, Robin M. T. Cooke, Francesco Fallani and Mohsen Farsad and has published in prestigious journals such as Journal of the American College of Cardiology, Nature Reviews Cardiology and International Journal of Cardiology.

In The Last Decade

Letizia Riva

29 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy

2005 607 citations Enrica Perugini, Pier Luigi Guidalotti et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Letizia Riva

Since Specialization

Citations

This map shows the geographic impact of Letizia Riva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Letizia Riva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Letizia Riva more than expected).

Fields of papers citing papers by Letizia Riva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Letizia Riva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Letizia Riva. The network helps show where Letizia Riva may publish in the future.

Co-authorship network of co-authors of Letizia Riva

This figure shows the co-authorship network connecting the top 25 collaborators of Letizia Riva. A scholar is included among the top collaborators of Letizia Riva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Letizia Riva. Letizia Riva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of DOACs in frail elderly patients in light of class genericization 2024 ·International Journal of Cardiology ·Giovanni Luca Botto, (unknown), Paolo Colonna, (unknown), (unknown), Letizia Riva	2
2	Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology 2022 ·Vascular Pharmacology ·Giuseppe Patti, Ilaria Cavallari, Arturo Cesaro, Felice Gragnano, Letizia Riva, Fabio Fimiani, Claudio Cuccia, Claudio Fresco, Paolo Calabrò, Sergio Leonardi, Rossella Marcucci, Andrea Rubboli	6
3	Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 2020 ·European Journal of Internal Medicine ·Riccardo Cappato, Mauro Chiarito, Michela Giustozzi, Martina Briani, Hussam Ali, Letizia Riva, Gianluca Bonitta, Corrado Lodigiani, F Furlanello, Cristina Balla, Pierpaolo Lupo, Giulio Stefanini	6
4	Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism 2018 ·International Journal of Cardiology ·Letizia Riva, Walter Ageno, Giuseppe Di Pasquale, Giancarlo Agnelli, Andrea Rubboli	4
5	Gli effetti emodinamici della pressione positiva di fine espirazione 2017 ·Giornale italiano di cardiologia ·Marco Marini, Giorgio Caretta, (unknown), Fabiana Lucà, (unknown), (unknown), (unknown), Letizia Riva, (unknown), Nadia Aspromonte, Andrea Mortara, Renata De Maria, (unknown), Serafina Valente, Michele Massimo Gulizia	2
6	Ventilazione non invasiva e sedazione: evidenze a supporto e consigli pratici 2017 ·Giornale italiano di cardiologia ·(unknown), Marco Marini, Giorgio Caretta, (unknown), Fabiana Lucà, (unknown), (unknown), (unknown), Letizia Riva, (unknown), Nadia Aspromonte, Massimo Iacoviello, Renata De Maria, (unknown), Michele Massimo Gulizia	1
7	Nuovi anticoagulanti orali nella fibrillazione atriale: evidenze di efficacia e sicurezza nel mondo reale 2017 ·Giornale italiano di cardiologia ·Letizia Riva, Giuseppe Di Pasquale	2
8	Shock cardiogeno: dal trattamento farmacologico all’assistenza meccanica al circolo 2017 ·Giornale italiano di cardiologia ·(unknown), Marco Marini, (unknown), (unknown), Fabiana Lucà, (unknown), Giorgio Caretta, (unknown), Letizia Riva, (unknown), Massimo Iacoviello, Renata De Maria, Alessandro Navazio, Nadia Aspromonte, Andrea Di Lenarda, Michele Massimo Gulizia, Serafina Valente	2
9	Ventilazione non invasiva: caratteri generali, indicazioni e revisione della letteratura 2017 ·Giornale italiano di cardiologia ·(unknown), Marco Marini, Giorgio Caretta, Fabiana Lucà, (unknown), (unknown), (unknown), Letizia Riva, (unknown), Nadia Aspromonte, Daniela Pini, Alessandro Navazio, Renata De Maria, Serafina Valente, Michele Massimo Gulizia	2
10	Shock cardiogeno: dalla diagnosi precoce al monitoraggio multiparametrico 2017 ·Giornale italiano di cardiologia ·Marco Marini, (unknown), (unknown), (unknown), Fabiana Lucà, (unknown), Giorgio Caretta, (unknown), Letizia Riva, (unknown), Andrea Mortara, Daniela Pini, Renata De Maria, Nadia Aspromonte, Andrea Di Lenarda, Michele Massimo Gulizia, Serafina Valente	2
11	Calcificazione miocardica massiva idiopatica: una rara causa di insufficienza miocardica 2016 ·Giornale italiano di cardiologia ·(unknown), (unknown), Letizia Riva, Gianni Casella, (unknown), Giuseppe Di Pasquale	0
12	Indagine Censis sulla conoscenza in Italia della fibrillazione atriale a livello dei cittadini, dei medici di medicina generale e dei pazienti 2014 ·Giornale italiano di cardiologia ·Gian Franco Gensini, Giuseppe Di Pasquale, Concetta M. Vaccaro, Letizia Riva, Ido Iori, Carlo Nozzoli, Vittorio Pengo, Stefano Ricci, Massimo Santini, Danilo Toni	5
13	Terapia anticoagulante orale della fibrillazione atriale in Italia: a che punto siamo? 2014 ·Giornale italiano di cardiologia ·Giuseppe Di Pasquale, Letizia Riva, (unknown)	1
14	Decision making for oral anticoagulants in atrial fibrillation: The ATA-AF study 2013 ·European Journal of Internal Medicine ·Gualberto Gussoni, Giuseppe Di Pasquale, Giorgio Vescovo, Michele Massimo Gulizia, Giovanni Mathieu, Marino Scherillo, (unknown), Donata Lucci, Carlo Nozzoli, Gianna Fabbri, Fabrizio Colombo, Letizia Riva, (unknown), Aldo P. Maggioni, Antonino Mazzone	15
15	Profilassi cardioembolica 2011: siamo vicini al tramonto del warfarin? 2011 ·Giornale italiano di cardiologia ·Giuseppe Di Pasquale, Letizia Riva	1
16	Transthyretin-related amyloidoses and the heart: a clinical overview 2010 ·Nature Reviews Cardiology ·Claudio Rapezzi, Candida Cristina Quarta, Letizia Riva, Simone Longhi, Ilaria Gallelli, Massimiliano Lorenzini, Paolo Ciliberti, Elena Biagini, Fabrizio Salvi, Angelo Branzi	251
17	Gender-related risk of myocardial involvement in systemic amyloidosis 2008 ·Amyloid ·Claudio Rapezzi, Letizia Riva, Candida Cristina Quarta, Enrica Perugini, Fabrizio Salvi, Simone Longhi, Paolo Ciliberti, Francesca Pastorelli, Elena Biagini, Ornella Leone, Robin M. T. Cooke, Maria Letizia Bacchi Reggiani, Alessandra Ferlini, Michèle Cavo, Giampaolo Merlini, Stefano Perlini, Sonia Pasquali, Angelo Branzi	75
18	Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 2006 ·Amyloid ·Claudio Rapezzi, Enrica Perugini, Fabrizio Salvi, Francesco Grigioni, Letizia Riva, Robin M. T. Cooke, Alessandra Ferlini, Paola Rimessi, Maria Letizia Bacchi Reggiani, Paolo Ciliberti, Francesca Pastorelli, Ornella Leone, Ilaria Bartolomei, Antonio Daniele Pinna, Giorgio Arpesella, Angelo Branzi	44
19	[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril]. 2005 ·PubMed ·Claudio Rapezzi, Paolo Ciliberti, Maddalena Graziosi, Letizia Riva	1
20	Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy breakdown → 2005 ·Journal of the American College of Cardiology ·Enrica Perugini, Pier Luigi Guidalotti, Fabrizio Salvi, Robin M. T. Cooke, Cinzia Pettinato, Letizia Riva, Ornella Leone, Mohsen Farsad, Paolo Ciliberti, Maria Letizia Bacchi Reggiani, Francesco Fallani, Angelo Branzi, Claudio Rapezzi	607

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact